Huaxia Eye Hospital Group Co.,Ltd. (SHE:301267)

Market Cap	15.48B
Revenue (ttm)	4.09B
Net Income (ttm)	529.41M
Shares Out	833.42M
EPS (ttm)	0.63
PE Ratio	29.49
Forward PE	21.16
Dividend	0.11 (0.59%)
Ex-Dividend Date	Jul 15, 2024

Volume	4,029,100
Average Volume	5,671,399
Open	19.05
Previous Close	19.28
Day's Range	19.05 - 19.42
52-Week Range	15.90 - 29.40
Beta	0.61
RSI	41.37
Earnings Date	Apr 28, 2025

About Huaxia Eye Hospital Group

Huaxia Eye Hospital Group Co.,Ltd. operates an ophthalmic medical chain in China and internationally. The company provides general ophthalmology diagnosis and treatment services for patients with ophthalmic diseases. It offers services in the areas of refractive surgery, optometry, pediatric strabismus, cataract, fundus disease, ocular surface and corneal disease, glaucoma, eye trauma, and eye plastic surgery. The company was founded in 1997 and is based in Xiamen, China.

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1997
• Employees: 7,613
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301267

Financial Performance

In 2023, Huaxia Eye Hospital Group's revenue was 4.01 billion, an increase of 24.12% compared to the previous year's 3.23 billion. Earnings were 665.93 million, an increase of 29.60%.